StockTipsArenaBeta

BUY Epigral Limited — Emkay Global

BUYEpigral Limited

byEmkay GlobalHorizon: NA (inferred 1 year)6 May 2025via Institutional / Brokerage Research

Entry₹1,779.6Inferred
Target₹2,450
Total upside +37.67% (call closed)
Stop lossNot given
At expiry₹1,3646 May 2026, 3:30 pm
Expired-23.35%
Follow Emkay Global for new calls(65% target hit, 397 closed calls)Get alertsWatch EPIGRAL for new buy/sell callsGet alertsSee 69 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 3:28 pm IST
2 supporting1 neutral0 opposing
Supports the BUY call (2)

Epigral Limited reported record Q4FY26 revenue of Rs 736 Cr, up 17% YoY, and proposed a final dividend of Rs 5 per share. The company also announced strategic updates including capex plans for CPVC an

NSE · Press Release·2 May · 3d ago

(opens in new tab)

Epigral Limited's Board of Directors approved the audited financial results for the fourth quarter and year ended March 31, 2026. The company also recommended a final dividend of Rs. 5.00 per equity s

NSE · Outcome of Board Meeting·2 May · 3d ago

(opens in new tab)
Neutral / worth noting (1)

Approved Audited Financial Results (Standalone & Consolidated) for the Fourth Quarter and Year ended on 31st March, 2026 and Recommended Final dividend of Rs. 5.00 (50%) per Equity Share ....

BSE · Board Meeting·2 May · 3d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.